MedTrace Logo

19Gauge Fine Needle Biopsy (FNB) Versus 22Gauge FNB for Endoscopic Ultrasound Guided Liver Biopsy (EUS-LB)

NCT04806607 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2022-04-20

No results posted yet for this study

Summary

To determine the adequacy of EUS-LB using a 19G core needle compared to a 22G core needle in a prospective randomized study.

Conditions

Interventions

PROCEDURE

19G FNB

Biopsy specimen adequacy using the 19G FNB

PROCEDURE

22G FNB

Biopsy specimen adequacy using the 22G FNB.

Sponsors & Collaborators

  • Geisinger Clinic

    lead OTHER

Principal Investigators

  • David L Diehl, MD · Geisinger Clinic

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-30
Primary Completion
2022-03-16
Completion
2022-03-16

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04806607 on ClinicalTrials.gov